Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

NCT06232551 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
152000
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Scott C. Woller, MD

Collaborators